Upgraded Formulas, LLC – Trademark Portfolio
Entity Type: 16
Upgraded Formulas, LLC holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 9 trademarks are registered and 1 is pending. Notable registered marks include 8-HOUR SLEEP, TEST, DON'T GUESS, UPGRADED FORMULAS, BOTTLING THE BEST SCIENCE, and "THE BEST OF WHAT SCIENCE HAS TO OFFER.". The owner is based in Austin, TX.
#403
300 South Lamar
Austin, TX 78704
Showing of trademarks Trademarks
Trademark Classifications
Upgraded Formulas, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Upgraded Formulas, LLC have?
Upgraded Formulas, LLC has 12 U.S. trademarks filed with the USPTO. Of these, 9 registered, 1 pending, 2 abandoned.
What trademark classes does Upgraded Formulas, LLC file in?
Upgraded Formulas, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Upgraded Formulas, LLC's most well-known trademarks?
Upgraded Formulas, LLC's registered trademark portfolio includes well-known marks such as 8-HOUR SLEEP, TEST, DON'T GUESS, UPGRADED FORMULAS, BOTTLING THE BEST SCIENCE, and "THE BEST OF WHAT SCIENCE HAS TO OFFER.". These are among 9 currently registered trademarks in the portfolio.
What is Upgraded Formulas, LLC's trademark registration success rate?
Upgraded Formulas, LLC has a 82% trademark registration rate, with 9 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.